MAY 15, 2018 11:40 PM PDT

Targeting Protein Kinases for Anti-Cancer Drug Development

WRITTEN BY: Nouran Amin

The inactive form (left) of the MAPK p38 enzyme moves in an uncoordinated fashion. Once the necessary molecules (blue blob and P symbols) bind, the enzyme becomes active (right) by moving in a coordinated fashion to do its job inside a cell. Credit: Senthil Ganesan, University of Arizona Department of Chemistry and Biochemistry.

A protein kinase, an enzyme, might be the key to developing new cancer drugs according to a research study at the University of Arizona.

Protein Kinases work like switches that turn on and off certain cellular processes. If a cell's kinases stop working, the cell would die. Now, the University of Arizona (UA) research team has figured out the full pathway for activating a protein kinase. "Kinases are one of the major cancer drug targets,” explains senior author of the study and member of the UA BIO5 Institute and the UA Cancer Center, Wolfgang Peti. "If you know how a kinase works, you can definitely better design your drugs against it."

Creating a drug that utilizes these research findings will most likely take at least 10 years. However, there exists some cancer drugs already in use that target kinases. These drugs are dasatinib and imatinib for chronic myeloid leukemia (CML) and afatinib for non-small cell lung carcinoma (NSCLC).

Investigators used a nuclear magnetic resonance (NMR) spectroscopy to observe a particular protein kinase called mitogen-activated protein kinase (MAPK) p38 molecular pathway.

All crucial molecules had to bind to p38 for the kinase to be activated and exert its normal functions. "We figured out how it moves to do its job and what is the contribution of speed of movement to its job," Peti said. These research findings suggest a new route for developing anti-cancer drugs, and that is targeting the p38 pathway. "We are excited because this kinase belongs to a family of kinases that are called MAP kinases—key signaling kinases that regulate a plethora of pathways (within cells)," he said. This finding can also apply to other protein kinases

The idea is that enzymes can be thought of as a lock and a key. For example, a molecule can serve as the key when it fits into a site in the enzyme, which is serving as the lock. Once the key is in the lock, the enzyme can start working.

The key-in-the-lock is important for an enzyme to be activated, which isn't always easy. Some researchers proposed that that dynamics—the way and speed at which an enzyme moves—is necessary for activating kinase enzymes.

Peti is also interested in how kinases govern cellular processes, which inspired him to investigate the role of biochemical dynamics. Unfortunately, studying the role that dynamics plays in the activation of p38 was more difficult and took longer than expected.

Sources: Proceedings of the National Academy of Sciences

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 04, 2018
Drug Discovery
JUL 04, 2018
First Drug Approved for The Treatment of Hyperhidrosis
Hyperhidrosis is a chronic skin condition that results in the increased production of sweat than needed. A certain amount of sweat is normally produced to ...
JUL 31, 2018
Drug Discovery
JUL 31, 2018
Two Molecules Identified For Treating Traumatic Brain Injury (TBI)
Scientists at Rutgers University have discovered two molecules that protect nerve cells, serving as motivation to develop new drugs for brain damage. The d...
AUG 08, 2018
Drug Discovery
AUG 08, 2018
Cholesterol Pill For Treating A Brutal Lung Disease
A brutal lung disease called Pulmonary Alveolar Proteinosis (PAP) is caused by a thick substance known as surfactant that clogs up the air sacs in the lung...
AUG 19, 2018
Cardiology
AUG 19, 2018
Three in One Pill Lowers Blood Pressure
New pill that combines three high blood pressure medication into one pill is both more effective and safe....
SEP 18, 2018
Drug Discovery
SEP 18, 2018
Compound Prevents Malaria Transmission in Mosquitoes
In a publication in Nature Communications, scientists from the Imperial College London have recently screened 70,000 compounds and were able to find just 6...
OCT 06, 2018
Drug Discovery
OCT 06, 2018
New Class of Drugs for Breast Cancer Therapy
Scientists at Stevens Institute of Technology have designed a new class of molecules that may hold the potential to add to the arsenal of drugs actively be...
Loading Comments...